Neogen Corp (NEOG): Cash & Equivalents
$185.50M
As of 2026-05-31
+4.4%
3-year compound annual growth
+19.7%
5-year compound annual growth
+12.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $185.50M | +43.8% | 2026-07-30, Balance as of period end |
| 2025-05-31 | $129.00M | -24.4% | 2026-07-30, Balance as of period end |
| 2024-05-31 | $170.61M | +4.5% | 2025-07-30, Balance as of period end |
| 2023-05-31 | $163.24M | +267.1% | 2024-07-30, Balance as of period end |
| 2022-05-31 | $44.47M | -41.2% | 2023-08-15, Balance as of period end |
| 2021-05-31 | $75.60M | +14.1% | 2022-07-27, Balance as of period end |
| 2020-05-31 | $66.27M | +59.0% | 2021-07-30, Balance as of period end |
| 2019-05-31 | $41.69M | -49.8% | 2021-07-30, Balance as of period end |
| 2018-05-31 | $83.07M | +7.1% | 2020-07-30, Balance as of period end |
| 2017-05-31 | $77.57M | +40.4% | 2019-07-30, Balance as of period end |
| 2016-05-31 | $55.26M | -16.4% | 2018-07-27, Balance as of period end |
| 2015-05-31 | $66.06M | +62.4% | 2017-07-28, Balance as of period end |
| 2014-05-31 | $40.67M | -18.7% | 2016-07-29, Balance as of period end |
| 2013-05-31 | $50.03M | +2.0% | 2015-07-30, Balance as of period end |
| 2012-05-31 | $49.05M | +36.8% | 2014-07-30, Balance as of period end |
| 2011-05-31 | $35.84M | +57.2% | 2013-07-30, Balance as of period end |
| 2010-05-31 | $22.81M | n/a | 2012-07-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Neogen Corp (NEOG) | 2026-05-31 | $185.50M | +43.8% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $149.60M | +46.1% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $359.12M | -60.7% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $169.80M | +72.7% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $180.07M | -37.5% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $155.46M | -17.8% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $5.91M | +59.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $3.81M | +1.3% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $1.75M | -0.8% |
Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗